Stocktoria

ZeroStack Corp. ZSTK

Nasdaq · XNAS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2021-05-11

ZeroStack Corp. financials (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Revenue$35.7M$35.9M$76.1M$33.4M$9.0M
Gross profit$1.6M$2.2M$17.7M$13.3M$2.4M
R&D expense$418,000$62,000$388,000$132,000
Operating income-$154.7M-$8.9M-$50.4M-$47.2M-$19.0M
Income tax$59,000$22,000-$1.6M-$1.4M-$98,000
Net income-$15.9M-$57.0M-$52.4M-$21.4M
EPS (diluted)$-43.49$-50.02$-7.75$-13.68
Operating cash flow-$8.7M-$5.0M-$8.4M-$15.9M-$20.9M
Free cash flow-$8.8M-$5.2M-$8.6M-$17.2M-$24.9M
Cash & equivalents$5.6M$5.2M$4.3M$8.9M$37.6M
Inventory$1.9M$2.2M$8.5M$8.7M$3.0M
Total assets$130.2M$26.2M$23.6M$81.0M$85.5M
Total liabilities$59.7M$21.7M$17.2M$24.6M$8.5M
Shareholders' equity$70.6M$4.5M$6.4M$56.8M$77.2M

Source: SEC EDGAR filings · CIK 0001790169 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.